Researchers from the Tumor Profiler consortium have combined single-cell multi-omics and functional profiling for 21 AML ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy ... the BPTF ...

Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.

"We are incredibly grateful to the esteemed AML thought leaders who took time out of their busy schedules to share their valuable insight at our recent event ... treatment of relapsed or refractory ...

"We are incredibly grateful to the esteemed AML thought leaders who took time out of their busy schedules to share their valuable insight at our recent event. Their continued enthusiasm and ...

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to conventional therapies and their similarity to normal hematopoietic stem cells (HSCs). Recent research ...